Do Evidence Review Groups Bias NICE Decisions?
ERGs are independent academic organizations commissioned by NICE to act objectively, but how much influence do they have on reimbursement decisions and cost-effectiveness assessments?
Our webinar explores the potential bias and policy / industry implications:
- If ERGs are supposed to be independent and objective, will there be differences among the groups?
- Do ERGs cover different therapeutic areas?
- Are there different rates of positive decisions between the ERGs?
- Are some ERGs more critical of the economic evidence?